Kymera Therapeutics (KYMR) PT Raised to $120 at Mizuho
Tweet Send to a Friend
Mizuho analyst Joseph Catanzaro raised the price target on Kymera Therapeutics (NASDAQ: KYMR) to $120.00 (from $81.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
